- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Update on settlement
- Holding(s) in Company - Replacement
- Holding(s) in Company
- New shares registered with Finnish Trade Register
- Fully subscribed EUR 30.7 million share offering
- Proposed REX Retail Offer
- Faron commences a share offering
- Initial positive data from Phase 2 of BEXMAB
- Issuance of warrants
- Founders named European Inventor Award finalists
More ▼
Key statistics
On Friday, Faron Pharmaceuticals Oy (FARN:LSE) closed at 98.50, 15.88% above the 52 week low of 85.00 set on Jun 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 101.00 |
---|---|
High | 95.00 |
Low | 95.00 |
Bid | 90.00 |
Offer | 105.00 |
Previous close | 101.00 |
Average volume | 82.62k |
---|---|
Shares outstanding | 104.62m |
Free float | 71.27m |
P/E (TTM) | -- |
Market cap | 105.67m GBP |
EPS (TTM) | -0.2818 GBP |
Data delayed at least 20 minutes, as of Jun 28 2024 16:36 BST.
More ▼